Strategies to reverse endothelial dysfunction in diabetic nephropathy

Kidney International

Volumn 82, Issue 11, 2012, Pages 1151-1154

  Badal, Shawn S ^a   Danesh, Farhad R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SEPIAPTERIN; TETRAHYDROBIOPTERIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ALBUMINURIA; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIMERIZATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; REVIEW; VASCULAR ENDOTHELIUM;

EID: 84869187092     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.306     Document Type: Note

References (10)

1. Cheng H, Wang H, Fan X et al. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int 2012; 82: 1176-1183.
2. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B et al. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; 1: 461-463. (Pubitemid 19063530)
3. Jensen T. Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy. BMJ 1989; 298: 27-28. (Pubitemid 19022886)
4. Huang PL, Huang Z, Mashimo H et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242.
5. Zhao HJ, Wang S, Cheng H et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006; 17: 2664-2669. (Pubitemid 44484656)
6. Nakagawa T, Sato W, Glushakova O et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550. (Pubitemid 46193319)
7. Kureishi Y, Luo Z, Shiojima I et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6: 1004-1010.
8. Guzik TJ, Mussa S, Gastaldi D et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656-1662. (Pubitemid 34298608)
9. Vasquez-Vivar J, Kalyanaraman B, Martasek P et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95: 9220-9225. (Pubitemid 28506212)
10. Tsutsui M, Milstien S, Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res 1996; 79: 336-342. (Pubitemid 26255888)